Howard G. Welgus
CIK: 0001801050
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Arcutis Biotherapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (50 total)
- Oct 15, 2026ARQT
Arcutis Biotherapeutics, Inc.
Exercise(M)Direct1K shares at avg. $7.51$8K - Oct 15, 2026ARQT
Arcutis Biotherapeutics, Inc.
Exercise(M)Direct822 shares at avg. $6.52$5K - Oct 15, 2026ARQT
Arcutis Biotherapeutics, Inc.
Sale(S)Direct4.7K shares at avg. $26.93$127K - Oct 15, 2026ARQT
Arcutis Biotherapeutics, Inc.
Exercise(M)Direct2.3K shares at avg. $8.63$19K - Sep 15, 2026ARQT
Arcutis Biotherapeutics, Inc.
Exercise(M)Direct1K shares at avg. $7.51$8K - Sep 15, 2026ARQT
Arcutis Biotherapeutics, Inc.
Exercise(M)Direct2.3K shares at avg. $8.63$19K - Sep 15, 2026ARQT
Arcutis Biotherapeutics, Inc.
Sale(S)Direct4.7K shares at avg. $24.18$114K - Sep 15, 2026ARQT
Arcutis Biotherapeutics, Inc.
Exercise(M)Direct822 shares at avg. $6.52$5K - Aug 17, 2026ARQT
Arcutis Biotherapeutics, Inc.
Exercise(M)Direct822 shares at avg. $6.52$5K - Aug 17, 2026ARQT
Arcutis Biotherapeutics, Inc.
Exercise(M)Direct2.3K shares at avg. $8.63$19K - Aug 17, 2026ARQT
Arcutis Biotherapeutics, Inc.
Sale(S)Direct4.7K shares at avg. $26.18$124K - Aug 17, 2026ARQT
Arcutis Biotherapeutics, Inc.
Exercise(M)Direct1K shares at avg. $7.51$8K - Jul 15, 2026ARQT
Arcutis Biotherapeutics, Inc.
Exercise(M)Direct822 shares at avg. $6.52$5K - Jul 15, 2026ARQT
Arcutis Biotherapeutics, Inc.
Sale(S)Direct4.7K shares at avg. $26.91$127K - Jul 15, 2026ARQT
Arcutis Biotherapeutics, Inc.
Exercise(M)Direct2.3K shares at avg. $8.63$19K - Jul 15, 2026ARQT
Arcutis Biotherapeutics, Inc.
Exercise(M)Direct1K shares at avg. $7.51$8K - Jun 17, 2026ARQT
Arcutis Biotherapeutics, Inc.
Sale(S)Direct635 shares at avg. $25.67$16K - Jun 15, 2026ARQT
Arcutis Biotherapeutics, Inc.
Sale(S)Direct4.1K shares at avg. $24.41$100K - Jun 15, 2026ARQT
Arcutis Biotherapeutics, Inc.
Exercise(M)Direct822 shares at avg. $6.52$5K - Jun 15, 2026ARQT
Arcutis Biotherapeutics, Inc.
Exercise(M)Direct1K shares at avg. $7.51$8K - Jun 15, 2026ARQT
Arcutis Biotherapeutics, Inc.
Exercise(M)Direct2.3K shares at avg. $8.63$19K - Jun 5, 2026ARQT
Arcutis Biotherapeutics, Inc.
Award(A)Direct5.8K shares- - May 1, 2026ARQT
Arcutis Biotherapeutics, Inc.
Sale(S)Direct7.1K shares at avg. $22.99$164K - Apr 1, 2026ARQT
Arcutis Biotherapeutics, Inc.
Sale(S)Direct10K shares at avg. $23.88$239K - Mar 2, 2026ARQT
Arcutis Biotherapeutics, Inc.
Sale(S)Direct10K shares at avg. $25.65$257K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 15, 2026 | ARQT Arcutis Biotherapeutics, Inc. | Exercise(M) | 1,018 | $7.51 | $7,645 | Direct |
| Oct 15, 2026 | ARQT Arcutis Biotherapeutics, Inc. | Exercise(M) | 822 | $6.52 | $5,361 | Direct |
| Oct 15, 2026 | ARQT Arcutis Biotherapeutics, Inc. | Sale(S) | 4,728 | $26.93 | $127,325 | Direct |
| Oct 15, 2026 | ARQT Arcutis Biotherapeutics, Inc. | Exercise(M) | 2,254 | $8.63 | $19,452 | Direct |
| Sep 15, 2026 | ARQT Arcutis Biotherapeutics, Inc. | Exercise(M) | 1,019 | $7.51 | $7,653 | Direct |
| Sep 15, 2026 | ARQT Arcutis Biotherapeutics, Inc. | Exercise(M) | 2,255 | $8.63 | $19,461 | Direct |
| Sep 15, 2026 | ARQT Arcutis Biotherapeutics, Inc. | Sale(S) | 4,730 | $24.18 | $114,371 | Direct |
| Sep 15, 2026 | ARQT Arcutis Biotherapeutics, Inc. | Exercise(M) | 822 | $6.52 | $5,361 | Direct |
| Aug 17, 2026 | ARQT Arcutis Biotherapeutics, Inc. | Exercise(M) | 822 | $6.52 | $5,361 | Direct |
| Aug 17, 2026 | ARQT Arcutis Biotherapeutics, Inc. | Exercise(M) | 2,255 | $8.63 | $19,461 | Direct |
| Aug 17, 2026 | ARQT Arcutis Biotherapeutics, Inc. | Sale(S) | 4,730 | $26.18 | $123,835 | Direct |
| Aug 17, 2026 | ARQT Arcutis Biotherapeutics, Inc. | Exercise(M) | 1,019 | $7.51 | $7,653 | Direct |
| Jul 15, 2026 | ARQT Arcutis Biotherapeutics, Inc. | Exercise(M) | 822 | $6.52 | $5,361 | Direct |
| Jul 15, 2026 | ARQT Arcutis Biotherapeutics, Inc. | Sale(S) | 4,730 | $26.91 | $127,284 | Direct |
| Jul 15, 2026 | ARQT Arcutis Biotherapeutics, Inc. | Exercise(M) | 2,255 | $8.63 | $19,461 | Direct |
| Jul 15, 2026 | ARQT Arcutis Biotherapeutics, Inc. | Exercise(M) | 1,019 | $7.51 | $7,653 | Direct |
| Jun 17, 2026 | ARQT Arcutis Biotherapeutics, Inc. | Sale(S) | 635 | $25.67 | $16,300 | Direct |
| Jun 15, 2026 | ARQT Arcutis Biotherapeutics, Inc. | Sale(S) | 4,096 | $24.41 | $99,980 | Direct |
| Jun 15, 2026 | ARQT Arcutis Biotherapeutics, Inc. | Exercise(M) | 822 | $6.52 | $5,361 | Direct |
| Jun 15, 2026 | ARQT Arcutis Biotherapeutics, Inc. | Exercise(M) | 1,019 | $7.51 | $7,653 | Direct |
| Jun 15, 2026 | ARQT Arcutis Biotherapeutics, Inc. | Exercise(M) | 2,255 | $8.63 | $19,461 | Direct |
| Jun 5, 2026 | ARQT Arcutis Biotherapeutics, Inc. | Award(A) | 5,778 | - | $0 | Direct |
| May 1, 2026 | ARQT Arcutis Biotherapeutics, Inc. | Sale(S) | 7,144 | $22.99 | $164,220 | Direct |
| Apr 1, 2026 | ARQT Arcutis Biotherapeutics, Inc. | Sale(S) | 10,000 | $23.88 | $238,801 | Direct |
| Mar 2, 2026 | ARQT Arcutis Biotherapeutics, Inc. | Sale(S) | 10,000 | $25.65 | $256,518 | Direct |
1-25 of 50 transactions
About Welgus Howard G.
Welgus Howard G. (SEC CIK 0001801050) files insider reports with the SEC as Director of Arcutis Biotherapeutics, Inc. (ARQT).
Signal8 holds 28 ownership filings by Welgus Howard G., all Form 4s, filed between Sep 5, 2024 and Oct 19, 2026. Those filings report 50 transactions, from Sep 3, 2024 to Oct 15, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Welgus Howard G.'s filings is in WESTLAKE VILLAGE, CA.
Recent filings by Welgus Howard G.
- Oct 15, 2026: Option exercises of ARQT shares (2 lines, Form 4, code M).
- Oct 15, 2026: Open-market sale of ARQT shares (Form 4, code S).
- Oct 15, 2026: Option exercise of ARQT shares (Form 4, code M).
- Sep 15, 2026: Option exercises of ARQT shares (2 lines, Form 4, code M).
- Sep 15, 2026: Open-market sale of ARQT shares (Form 4, code S).
Other insiders filing for Arcutis Biotherapeutics, Inc. (ARQT)
- SCOTT ROBERT A, Director
- Matsuda Masaru
- Curran Terrie, Director
- Burnett Patrick
- Watanabe Todd
- Peetz Christopher, Director